The latest genomic analysis of pancreatic tumors identified two new pathways involved in the disease, information that could be capitalized on to develop new and earlier diagnostic tests for the disease. “We now know every gene involved in pancreatic cancer,” said Dr. William Fisher, professor of surgery and director of the Elkins Pancreas Center at BCM. “This study ushers in a whole new era of taking care of patients with pancreatic cancer. We will look back on this as a turning point in understanding and treating this disease.”
